Functional endpoints in patients with geographic atrophy: What to consider when designing a clinical trial.

Dinah C, Esmaeelpour M, Rachitskaya AV, De Salvo G, Munk MR.

Open source

DOI
10.1016/j.preteyeres.2025.101421
Published
2025-12-04
Container
Prog Retin Eye Res
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.preteyeres.2025.101421,
  title = {Functional endpoints in patients with geographic atrophy: What to consider when designing a clinical trial.},
  author = {Dinah C and  Esmaeelpour M and  Rachitskaya AV and  De Salvo G and  Munk MR.},
  year = {2026},
  journal = {Prog Retin Eye Res},
  doi = {10.1016/j.preteyeres.2025.101421},
  url = {https://doi.org/10.1016/j.preteyeres.2025.101421}
}

RIS

TY  - JOUR
TI  - Functional endpoints in patients with geographic atrophy: What to consider when designing a clinical trial.
AU  - Dinah C
AU  -  Esmaeelpour M
AU  -  Rachitskaya AV
AU  -  De Salvo G
AU  -  Munk MR.
PY  - 2026
JO  - Prog Retin Eye Res
DO  - 10.1016/j.preteyeres.2025.101421
UR  - https://doi.org/10.1016/j.preteyeres.2025.101421
ER  - 

APA

C, D., M, E., AV, R., G, D. S., & MR., M. (2026). Functional endpoints in patients with geographic atrophy: What to consider when designing a clinical trial.. Prog Retin Eye Res. https://doi.org/10.1016/j.preteyeres.2025.101421

Source records